abrdn Life Sciences Investors (HQL)
We have not processed filings for abrdn Life Sciences Investors yet. This page fills in on its own once we have read them.
What abrdn Life Sciences Investors does
Its shares trade on NYSE under the ticker HQL.
Latest SEC filings
What abrdn Life Sciences Investors has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 28, 2026Form NPORT-P filing NPORT-P
- August 21, 2026Form N-PX filing N-PX
- June 8, 2026Form N-CSRS filing N-CSRS
- May 29, 2026Form NPORT-P filing NPORT-P
- March 6, 2026Passive stake changed SCHEDULE 13G/A
- February 27, 2026Form NPORT-P filing NPORT-P
- February 23, 2026Activist stake changed SCHEDULE 13D/A
- February 11, 2026Activist stake changed SCHEDULE 13D/A
- January 8, 2026Activist stake changed SCHEDULE 13D/A
- December 8, 2025Form N-CSR filing N-CSR
Questions about HQL
What does abrdn Life Sciences Investors do?
Its shares trade on NYSE under the ticker HQL.
When did abrdn Life Sciences Investors last report?
Its newest filing of any kind is the form NPORT-P filing from August 28, 2026.
Similar companies
Follow HQL
Get an email when abrdn Life Sciences Investors files with the SEC: results, executive changes, material agreements and annual reports.
Follow HQL: get an email when it filesWhere the numbers come from
Financial figures are the values abrdn Life Sciences Investors tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.